|  Help  |  About  |  Contact Us

Publication : Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis.

First Author  Boulaftali Y Year  2011
Journal  Circulation Volume  123
Issue  12 Pages  1326-34
PubMed ID  21403095 Mgi Jnum  J:183746
Mgi Id  MGI:5319163 Doi  10.1161/CIRCULATIONAHA.110.000885
Citation  Boulaftali Y, et al. (2011) Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis. Circulation 123(12):1326-34
abstractText  BACKGROUND: Protease nexin-1 (PN-1) is a serpin that inhibits plasminogen activators, plasmin, and thrombin. PN-1 is barely detectable in plasma, but we have shown recently that PN-1 is present within the alpha-granules of platelets. METHODS AND RESULTS: In this study, the role of platelet PN-1 in fibrinolysis was investigated with the use of human platelets incubated with a blocking antibody and platelets from PN-1-deficient mice. We showed by using fibrin-agar zymography and fibrin matrix that platelet PN-1 inhibited both the generation of plasmin by fibrin-bound tissue plasminogen activator and the activity of fibrin-bound plasmin itself. Rotational thromboelastometry and laser scanning confocal microscopy were used to demonstrate that PN-1 blockade or deficiency resulted in increased clot lysis and in an acceleration of the lysis front. Protease nexin-1 is thus a major determinant of the lysis resistance of platelet-rich clots. Moreover, in an original murine model in which thrombolysis induced by tissue plasminogen activator can be measured directly in situ, we observed that vascular recanalization was significantly increased in PN-1-deficient mice. Surprisingly, general physical health, after tissue plasminogen activator-induced thrombolysis, was much better in PN-1-deficient than in wild-type mice. CONCLUSIONS: Our results reveal that platelet PN-1 can be considered as a new important regulator of thrombolysis in vivo. Inhibition of PN-1 is thus predicted to promote endogenous and exogenous tissue plasminogen activator-mediated fibrinolysis and may enhance the therapeutic efficacy of thrombolytic agents.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression